The authors describe an 'unexpected metabolic rewiring' where i.p. olanzapine causes hepatic ATP depletion and AMPK activation despite increased lipogenic gene expression. This counterintuitive metabolic state lacks mechanistic explanation but appears protective against steatosis. Gap type: unexplained_observation Source paper: Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition. (None, None, PMID:37230004)
Landscape Summary: What causes the paradoxical ATP depletion and starvation-like metabolic signature during intraperitoneal olanzapine treatment? is a 0.76 priority gap in neurometabolism. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What causes the paradoxical ATP depletion and starvation-like metabolic signature during intraperitoneal olanzapine treatment? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: